LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
WASHINGTON, DC...
On March 15,...
Smartphone apps...
Even before the...
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.
Recently unveiled program aims to ensure easy access to COVID-19 treatments for all eligible Americans.